Spain · AEMPS CIMA

CERNEVIT POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
60022
Form
LIOFILIZADO PARA SOLUCIÓN INYECTABLE
Composition / generic term
multicomponente
Source strength
-
Authorisation holder
Baxter S.L.
Marketed in source snapshot
Yes

Source-listed ingredients

  • NICOTINAMIDA — 46 mg
  • DEXPANTENOL — 16,15 mg
  • FOLICO ACIDO — 0,414 mg
  • TODO-ALFA-TOCOFEROL — 10,2 mg
  • PIRIDOXINA HIDROCLORURO — 5,5 mg
  • COLECALCIFEROL — 220 UI
  • BIOTINA — 0,069 mg
  • CIANOCOBALAMINA — 0,006 mg
  • COCARBOXILASA — 5,8 mg
  • RIBOFLAVINA FOSFATO SODIO — 5,67 mg
  • ASCORBICO ACIDO — 125 mg
  • RETINOL PALMITATO — 3500 UI

These values do not establish equivalence or a dose recommendation.

Packages

  • CERNEVIT POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 10 viales

Source and coverage

Open AEMPS CIMA →

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →
CERNEVIT POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN — Spain | Molindra Medicines